Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 9779700

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1998 Oct
First author
Guglielmi C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Guglielmi C
      type
      Author
    2. name
      Gomez F
      type
      Author
    3. name
      Philip T
      type
      Author
    4. name
      Hagenbeek A
      type
      Author
    5. name
      Martelli M
      type
      Author
    6. name
      Sebban C
      type
      Author
    7. name
      Milpied N
      type
      Author
    8. name
      Bron D
      type
      Author
    9. name
      Cahn JY
      type
      Author
    10. name
      Somers R
      type
      Author
    11. name
      Sonneveld P
      type
      Author
    12. name
      Gisselbrecht C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Guglielmi C
      type
      Author
    2. name
      Gomez F
      type
      Author
    3. name
      Philip T
      type
      Author
    4. name
      Hagenbeek A
      type
      Author
    5. name
      Martelli M
      type
      Author
    6. name
      Sebban C
      type
      Author
    7. name
      Milpied N
      type
      Author
    8. name
      Bron D
      type
      Author
    9. name
      Cahn JY
      type
      Author
    10. name
      Somers R
      type
      Author
    11. name
      Sonneveld P
      type
      Author
    12. name
      Gisselbrecht C
      type
      Author
    bibliography ids
    1. nci-bib-325e738c6f3a8f49987c404d
    book metadata
    content sha256
    105eb83ba096ff664a8e072b0b65656302727152848f5a815b40754c37f160ba
    document type
    citation
    dois
    1. 10.1200/JCO.1998.16.10.3264
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9779700
    immutable id
    pubmed:9779700@105eb83ba096ff664a8e072b0b65656302727152848f5a815b40754c37f160ba
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    10
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3264-9
    volume
    16
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9779700
      provenance
      batch id
      7e001e36165c25a91a06
      provider
      NCBI PubMed ESummary
      record sha256
      0987475634a7b6148bebcf1b005f9b9b2ce443b7d999bc3a40cd600a67c56585
      response sha256
      3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
      retrieved at
      2026-09-09T23:45:31.509029+00:00
      publication date
      display
      1998 Oct
      precision
      month
      year
      1998
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase III
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9779700/
      title
      Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice